Gujarat Themis Biosyn Limited Incorporates Wholly Owned Subsidiary in Japan
Gujarat Themis Biosyn Limited has established its presence in Japan by incorporating a wholly owned subsidiary company. The new entity, named Themis Biosyn Japan Limited, was incorporated on May 19, 2026.The move marks a strategic expansion for Gujarat Themis Biosyn Limited within the Pharmaceutical Industry. The company now holds 100% of the shareholding in Themis Biosyn Japan Limited.
Key operational and financial details regarding the new subsidiary include:
| Detail | Value |
|---|---|
| Subsidiary Name | Themis Biosyn Japan Limited |
| Country of Incorporation | Japan |
| Initial Share Capital | Ten Lakhs Yen |
| Ownership Status | Wholly Owned Subsidiary |
| Industry | Pharmaceutical Industry |
| Date of Incorporation | May 19, 2026 |
Gujarat Themis Biosyn Limited has confirmed that the establishment of Themis Biosyn Japan Limited is an incorporation of a wholly owned subsidiary, meaning the transaction does not fall under related party transaction criteria, and the objective is purely related to corporate expansion.
GUJTHEM Stock Price Movement
Today, Gujarat Themis Biosyn Limited shares edged higher, gaining 0.32% to settle at ₹357.4. The stock traded on a total volume of 79,547 shares today, reflecting positive post-market sentiment for the pharmaceutical name.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.